Cargando…
Clinician Responses to Pediatric Lipid Screens Suggestive of Severe Dyslipidemia
OBJECTIVES: To measure case detection and response time of severe pediatric dyslipidemia, defined as non-high-density lipoprotein cholesterol (HDL-C) ≥190 mg/dL on the initial screening panel. Although low adherence to guidelines recommending universal pediatric lipid screening is well-documented, i...
Autores principales: | Zawacki, Amy W., Enright, Connor, Harris, Rachel E., Dodge, Ann, Peterson, Amy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236550/ https://www.ncbi.nlm.nih.gov/pubmed/37334253 http://dx.doi.org/10.1016/j.ympdx.2020.100037 |
Ejemplares similares
-
Screening and Management of Dyslipidemia in Children and Adolescents
por: Schefelker, Juliette M., et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on cardiometabolic health parameters in children with preexisting dyslipidemia
por: Schefelker, Juliette, et al.
Publicado: (2022) -
Feasibility of Lipid Screening During First Trimester of Pregnancy to Identify Women at Risk of Severe Dyslipidemia
por: Golwala, Sohil, et al.
Publicado: (2023) -
Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers
por: Lluesa, Julia Hernández, et al.
Publicado: (2022) -
Weight stigma and bias: A guide for pediatric clinicians
por: Braddock, Amy, et al.
Publicado: (2023)